当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:178.45亿  总市值:243.33亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金38,970,031,481.4624,947,508,365.8511,664,682,602.8254,186,457,995.91
收到的税费返还533,685.18286,278.54153,536.981,049,896.05
收到其他与经营活动有关的现金589,254,131.68383,300,949.39166,860,132.15289,149,874.92
经营活动现金流入的平衡项目0000
经营活动现金流入小计39,559,819,298.3225,331,095,593.7811,831,696,271.9554,476,657,766.88
购买商品、接受劳务支付的现金37,984,574,330.8824,770,668,013.2212,770,451,730.1748,496,799,804.84
支付给职工以及为职工支付的现金645,376,595.58451,503,135.68265,605,559.88847,889,302.22
支付的各项税费1,126,539,537.56799,136,706.34383,507,248.511,451,180,070.34
支付其他与经营活动有关的现金833,173,466.39375,766,082.62131,931,110.06954,131,491.95
经营活动现金流出的平衡项目0000
经营活动现金流出小计40,589,663,930.4126,397,073,937.8613,551,495,648.6251,750,000,669.35
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-1,029,844,632.09-1,065,978,344.08-1,719,799,376.672,726,657,097.53
二、投资活动产生的现金流量:
收回投资收到的现金22,922,454.7218,561,622.5118,561,622.517,878,681.73
取得投资收益收到的现金3,199,932.893,186,2205,343.397,773,419.32
处置固定资产、无形资产和其他长期资产收回的现金净额347,43085,64083,440161,051.16
投资活动现金流入的平衡项目0000
投资活动现金流入小计26,469,817.6121,833,482.5118,650,405.915,813,152.21
购建固定资产、无形资产和其他长期资产支付的现金100,543,198.6760,349,073.8919,604,382.45145,124,184.27
投资支付的现金1,375,7001,375,7001,375,700-
支付其他与投资活动有关的现金66,050,00166,050,001--
投资活动现金流出的平衡项目0000
投资活动现金流出小计167,968,899.67127,774,774.8920,980,082.45145,124,184.27
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-141,499,082.06-105,941,292.38-2,329,676.55-129,311,032.06
三、筹资活动产生的现金流量:
取得借款收到的现金283,109,437.63154,586,850.239,531,775203,195,997.9
收到其他与筹资活动有关的现金--328,666,029.88276,474,938.47
筹资活动现金流入平衡项目0000
筹资活动现金流入小计283,109,437.63154,586,850.23338,197,804.88479,670,936.37
偿还债务支付的现金267,256,996.13176,055,075.23100,000,000250,000,000
分配股利、利润或偿付利息支付的现金758,672,424.12733,820,077.1962,113,778.59780,138,629.31
其中:子公司支付给少数股东的股利、利润29,605,711.3628,733,351.8628,041,523.1770,560,925.09
支付其他与筹资活动有关的现金728,096,814.38391,334,317.8559,502,445.6781,708,180.85
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,754,026,234.631,301,209,470.27221,616,224.261,111,846,810.16
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,470,916,797-1,146,622,620.04116,581,580.62-632,175,873.79
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-2,642,260,511.15-2,318,542,256.5-1,605,547,472.61,965,170,191.68
加:期初现金及现金等价物余额10,798,318,043.1710,798,318,043.1710,798,318,043.178,833,147,851.49
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额8,156,057,532.028,479,775,786.679,192,770,570.5710,798,318,043.17
补充资料:
净利润-1,063,673,008.77-2,334,470,740.61
资产减值准备-4,052,580.83--388,870.07
固定资产和投资性房地产折旧-36,852,425.29-75,031,026.88
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-36,852,425.29-74,799,009.6
投资性房地产折旧---232,017.28
无形资产摊销-22,465,996.92-38,286,751.8
长期待摊费用摊销-4,189,464.4-8,572,884.72
递延收益摊销---8,288,892
处置固定资产、无形资产和其他长期资产的损失-54,073.85--83,443.4
固定资产报废损失-23,203.27-54,020.88
公允价值变动损失----10,817,458.31
财务费用-15,565,603.17-31,570,183.83
投资损失--240,328,388.92--358,951,819.35
递延所得税-14,872,073--7,194,611.2
其中:递延所得税资产减少-14,113,114.79--500,099.37
递延所得税负债增加-758,958.21--6,694,511.83
存货的减少--1,000,081,673.47--243,603,868.56
经营性应收项目的减少--2,212,606,663.11--292,548,102.02
经营性应付项目的增加-1,115,300,974.9-1,048,141,217.07
其他-4,206,210.33--
现金的期末余额-8,479,775,786.67-10,798,318,043.17
减:现金的期初余额-10,798,318,043.17-8,833,147,851.49
公告日期2024-10-242024-08-222024-04-262024-03-21
审计意见(境内)标准无保留意见
TOP↑